Canada · Delayed Price · Currency is CAD ME Therapeutics Holdings Statistics
Total Valuation
CSE:METX has a market cap or net worth of CAD 59.80 million. The enterprise value is 59.29 million.
| Market Cap | 59.80M |
| Enterprise Value | 59.29M |
Important Dates
The next estimated earnings date is Friday, July 17, 2026.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:METX has 30.05 million shares outstanding. The number of shares has increased by 11.85% in one year.
| Current Share Class | 30.05M |
| Shares Outstanding | 30.05M |
| Shares Change (YoY) | +11.85% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 56.35% |
| Owned by Institutions (%) | n/a |
| Float | 13.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 92.70 |
| P/TBV Ratio | 92.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.91 |
| Quick Ratio | 3.87 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -191.74 |
Financial Efficiency
Return on equity (ROE) is -111.03% and return on invested capital (ROIC) is -74.60%.
| Return on Equity (ROE) | -111.03% |
| Return on Assets (ROA) | -69.00% |
| Return on Invested Capital (ROIC) | -74.60% |
| Return on Capital Employed (ROCE) | -240.42% |
| Weighted Average Cost of Capital (WACC) | 4.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.05% in the last 52 weeks. The beta is 0.06, so CSE:METX's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -79.05% |
| 50-Day Moving Average | 3.63 |
| 200-Day Moving Average | 5.21 |
| Relative Strength Index (RSI) | 42.22 |
| Average Volume (20 Days) | 585 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.55M |
| Pretax Income | -1.38M |
| Net Income | -1.38M |
| EBITDA | -1.54M |
| EBIT | -1.55M |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has 536,518 in cash and 26,956 in debt, with a net cash position of 509,562 or 0.02 per share.
| Cash & Cash Equivalents | 536,518 |
| Total Debt | 26,956 |
| Net Cash | 509,562 |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 645,097 |
| Book Value Per Share | 0.02 |
| Working Capital | 438,776 |
Cash Flow
In the last 12 months, operating cash flow was -1.21 million and capital expenditures -75,817, giving a free cash flow of -1.29 million.
| Operating Cash Flow | -1.21M |
| Capital Expenditures | -75,817 |
| Depreciation & Amortization | 56,807 |
| Net Borrowing | -66,308 |
| Free Cash Flow | -1.29M |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:METX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.85% |
| Shareholder Yield | -11.85% |
| Earnings Yield | -2.31% |
| FCF Yield | -2.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |